Resveratrol induces downregulation of DNA repair genes in MCF-7 human breast cancer cells

European Journal of Cancer Prevention

Volumn 22, Issue 1, 2013, Pages 11-20

  Leon Galicia, Ismael ^a   Diaz Chavez, Jose ^b   Garcia Villa, Enrique ^a   Uribe Figueroa, Laura ^c   Hidalgo Miranda, Alfredo ^c   Herrera, Luis A ^b   Alvarez Rios, Elizabeth ^a   Garcia Mena, Jaime ^a   Gariglio, Patricio ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^c INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

Author keywords

anticancer drugs; DNA repair genes; homologous recombination; MRN complex; resveratrol

Indexed keywords

MESSENGER RNA; MRE11 PROTEIN; NIBRIN; RAD50 PROTEIN; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER RESISTANCE; CELL CYCLE REGULATION; CELL DEATH; CELL LEVEL; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA MICROARRAY; DNA REPAIR; DNA REPLICATION; DOSE RESPONSE; DOWN REGULATION; DRUG EFFICACY; DRUG SENSITIZATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IC 50; MICROARRAY ANALYSIS; MISMATCH REPAIR; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION;

ANGIOGENESIS INHIBITORS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; HUMANS; STILBENES;

EID: 84871024599     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328353edcb     Document Type: Article

References (44)

1. Abuzeid WM, Jiang X, Shi G, Wang H, Paulson D, Araki K, et al. (2009). Molecular disruption of RAD50 sensitizes human tumor cells to cisplatinbased chemotherapy. J Clin Invest 119:1974-1985
2. Alison MR, Hunt T, Forbes SJ (2002). Minichromosome maintenance (MCM) proteins may be pre-cancer markers. Gut 50:290-291
3. Alkhalaf M (2007). Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation. Eur J Cancer Prev 16:334-341
4. Bai Y, Mao QQ, Qin J, Zheng XY, Wang YB, Yang K, et al. (2010). Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci 101:488-493
5. Benitez DA, Hermoso MA, Pozo-Guisado E, Fernandez-Salguero PM, Castellon EA (2009). Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells. Prostate 69: 1045-1054
6. Bianchini F, Vainio H (2003). Wine and resveratrol: Mechanisms of cancer preventioñEur J Cancer Prev 12:417-425
7. Brito PM, Simoes NF, Almeida LM, Dinis TC (2008). Resveratrol disrupts peroxynitrite-triggered mitochondrial apoptotic pathway: A role for Bcl-2. Apoptosis 13:1043-1053
8. Chow AW, Murillo G, Yu C, van Breemen RB, Boddie AW, Pezzuto JM, et al. (2005). Resveratrol inhibits rhabdomyosarcoma cell proliferation. Eur J Cancer Prev 14:351-356
9. Dann JM, Sykes PH, Mason DR, Evans JJ (2009). Regulation of vascular endothelial growth factor in endometrial tumour cells by resveratrol and EGCG. Gynecol Oncol 113:374-378
10. Elattar TM, Virji AS (1999). The effect of red wine and its components on growth and proliferation of human oral squamous carcinoma cells. Anticancer Res 19:5407-5414
11. Freeman A, Morris LS, Mills AD, Stoeber K, Laskey RA,Williams GH, Coleman N (1999). Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 5:2121-2132
12. Fremont L (2000). Biological effects of resveratrol. Life Sci 66:663-673
13. Gatz SA, Keimling M, Baumann C, Dork T, Debatin KM, Fulda S, Wiesmuller L (2008). Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR-p53- and Nbs1-dependent manner. Carcinogenesis 29: 519-527
14. Helleday T, Lo J, van Gent DC, Engelward BP (2007). DNA double-strand break repair: From mechanistic understanding to cancer treatment. DNA Repair (Amst) 6:923-935
15. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220
16. Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein IB (2002). Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 8:893-903
17. Kearsey SE, Labib K (1998). MCM proteins: Evolution, properties, and role in DNA replication. Biochim Biophys Acta 1398:113-136
18. Kim MY, Trudel LJ, Wogan GN (2009). Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide production and caspase activation. Anticancer Res 29:3733-3740
19. Kim YA, Choi BT, Lee YT, Park DI, Rhee SH, Park KY, Choi YH (2004). Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells. Oncol Rep 11:441-446
20. Lavin MF (2007). ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene 26:7749-7758
21. Le Corre L, Fustier P, Chalabi N, Bignon YJ, Bernard-Gallon D (2004). Effects of resveratrol on the expression of a panel of genes interacting with the BRCA1 oncosuppressor in human breast cell lines. Clin Chim Acta 344: 115-121
22. Lee SK, Zhang W, Sanderson BJ (2008). Selective growth inhibition of human leukemia and human lymphoblastoid cells by resveratrol via cell cycle arrest and apoptosis induction. J Agric Food Chem 56:7572-7577
23. Lin HY, Sun M, Tang HY, Simone TM, Wu YH, Grandis JR, et al. (2008). Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells. J Cell Biochem 104:2131-2142
24. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408
25. Maiorano D, Lutzmann M, Mechali M (2006). MCM proteins and DNA replication. Curr Opin Cell Biol 18:130-136
26. Malhotra A, Nair P, Dhawan DK (2011). Curcumin and resveratrol synergistically stimulate p21 and regulate COX-2 by maintaining adequate zinc levels during lung carcinogenesis. Eur J Cancer Prev 20:411-416
27. Narayanan BA, Narayanan NK, Stoner GD, Bullock BP (2002). Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants. Life Sci 70:1821-1839
28. Narayanan BA, Narayanan NK, Re GG, Nixon DW (2003). Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int J Cancer 104:204-212
29. Nees M, Woodworth CD (2001). Microarrays: Spotlight on gene function and pharmacogenomics. Curr Cancer Drug Targets 1:155-175
30. Opipari AW Jr., Tan L, Boitano AE, Sorenson DR, Aurora A, Liu JR (2004). Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res 64:696-703
31. Park JW, Choi YJ, Suh SI, Baek WK, Suh MH, Jin IN, et al. (2001). Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis 22:1633-1639
32. Pisani P (1992). Breast cancer: Geographic variation and risk factors. J Environ Pathol Toxicol Oncol 11:313-316
33. Pozo-Guisado E, Alvarez-Barrientos A, Mulero-Navarro S, Santiago-Josefat B, Fernandez-Salguero PM (2002). The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: Cell-specific alteration of the cell cycle. Biochem Pharmacol 64: 1375-1386
34. Roy P, Kalra N, Prasad S, George J, Shukla Y (2009). Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharm Res 26:211-217
35. Sanders TH, McMichael RWJr., Hendrix KW (2000). Occurrence of resveratrol in edible peanuts. J Agric Food Chem 48:1243-1246
36. Sareen D, Darjatmoko SR, Albert DM, Polans AS (2007). Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol Pharmacol 72:1466-1475
37. Sengottuvelan M, Deeptha K, Nalini N (2009). Resveratrol attenuates 1,2-dimethylhydrazine (DMH) induced glycoconjugate abnormalities during various stages of colon carcinogenesis. Phytother Res 23: 1154-1158
38. Sobolev VS, Cole RJ (1999). Trans-resveratrol content in commercial peanuts and peanut products. J Agric Food Chem 47:1435-1439
39. Sorenson CM, Eastman A (1988). Mechanism of cis-diamminedichloroplatinum (II)-induced cytotoxicity: Role of G2 arrest and DNA double-strand breaks. Cancer Res 48:4484-4488
40. Stervbo U, Vang O, Bonnesen C (2006). Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells. Cell Prolif 39:479-493
41. Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, Chen CK, et al. (2004). Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 10:2190-2202
42. Wolter F, Stein J (2002). Resveratrol enhances the differentiation induced by butyrate in caco-2 colon cancer cells. J Nutr 132:2082-2086
43. Wolter F, Akoglu B, Clausnitzer A, Stein J (2001). Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr 131:2197-2203
44. Yalcin A (2004). Quantification of thioredoxin mRNA expression in the rat hippocampus by real-time PCR following oxidative stress. Acta Biochim Pol 51:1059-1065